Effects of galcanezumab on acute medication use and health care resource utilization in treatment-resistant migraine: results from randomized, double blind, placebo-controlled clinical trial, conquer. (2020). Headache Medicine, 11(Supplement), 27. https://doi.org/10.48208/HeadacheMed.2020.Supplement.27